- Home
- CCLD vs ITRM Comparison
CCLD vs ITRM Comparison
Compare CCLD & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- ITRM
- Stock Information
- Founded
- CCLD 1999
- ITRM 2015
- Country
- CCLD United States
- ITRM Ireland
- Employees
- CCLD N/A
- ITRM N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- ITRM Health Care
- Exchange
- CCLD Nasdaq
- ITRM Nasdaq
- Market Cap
- CCLD 56.7M
- ITRM 49.5M
- IPO Year
- CCLD 2014
- ITRM 2018
- Fundamental
- Price
- CCLD $2.79
- ITRM $1.54
- Analyst Decision
- CCLD Strong Buy
- ITRM Strong Buy
- Analyst Count
- CCLD 2
- ITRM 1
- Target Price
- CCLD $3.75
- ITRM $5.00
- AVG Volume (30 Days)
- CCLD 113.3K
- ITRM 671.4K
- Earning Date
- CCLD 11-12-2024
- ITRM 11-14-2024
- Dividend Yield
- CCLD N/A
- ITRM N/A
- EPS Growth
- CCLD N/A
- ITRM N/A
- EPS
- CCLD N/A
- ITRM N/A
- Revenue
- CCLD $111,014,000.00
- ITRM N/A
- Revenue This Year
- CCLD N/A
- ITRM N/A
- Revenue Next Year
- CCLD $0.71
- ITRM N/A
- P/E Ratio
- CCLD N/A
- ITRM N/A
- Revenue Growth
- CCLD N/A
- ITRM N/A
- 52 Week Low
- CCLD $1.01
- ITRM $0.81
- 52 Week High
- CCLD $4.84
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- CCLD 39.20
- ITRM 39.39
- Support Level
- CCLD $2.60
- ITRM $1.58
- Resistance Level
- CCLD $3.91
- ITRM $2.10
- Average True Range (ATR)
- CCLD 0.36
- ITRM 0.14
- MACD
- CCLD -0.12
- ITRM -0.04
- Stochastic Oscillator
- CCLD 13.12
- ITRM 11.11
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.